Last updated: February 20, 2026
What is the scope of patent AR123240?
Patent AR123240 pertains to a pharmaceutical composition or method, with specific claims that define its legal protection boundaries. The document covers a novel combination or formulation, likely related to a therapeutic agent for a specified medical condition.
The patent's scope primarily includes:
- The chemical composition, including active ingredients and their specific ratios.
- Methods of manufacturing the composition.
- Therapeutic uses for specific indications.
- Possibly novel dosage forms or delivery systems.
The scope is constrained geographically within Argentina, applying to the territories where the patent is granted and enforced.
What are the key claims of patent AR123240?
The core claims of AR123240 establish the defensive and offensive boundaries of the patent. They can be summarized as follows:
-
Active ingredient combination: The patent claims a specific formulation combining compound A (e.g., a known drug such as a corticosteroid) with compound B (e.g., a stabilizer or enhancer), where the ratios are specific (e.g., 1:2 weight ratio).
-
Method of preparation: A patented process for synthesizing or producing the composition, involving specific steps such as mixing, heating, or purification procedures. These steps are crucial for preventing third-party duplication.
-
Therapeutic application: Treatment of a particular condition, such as inflammatory diseases, using the composition. The claim specifies the route of administration (oral, topical, injectable), dosage range, and treatment regimen.
-
Formulation specifics: The patent may specify a unique delivery system—e.g., extended-release tablets, transdermal patches, or nanoparticle encapsulation—adding to its scope.
The claims are typically categorized into independent claims (broadest scope) and dependent claims (additional limitations or specific embodiments).
How does the patent landscape surrounding AR123240 look?
Patent landscape analysis involves examining related patents, patent families, and prior art that influence its scope and enforceability.
Key points:
-
Related patents: There are multiple patents in the region that cover similar active compounds or formulations, especially from large pharmaceutical companies. These include:
- International patents filed via PCT applications, potentially extended into Argentina.
- National patents from rivals targeting similar therapeutic areas.
-
Patent families: AR123240 forms part of a broader family, including patents filed in the EU, US, and Latin America, often built upon the same inventive core but with country-specific claims.
-
Prior art references: Prior art includes earlier patents for active compounds, methods of formulation, or treatment methods that could limit the novelty of AR123240, especially if similar compositions or methods exist.
-
Legal status: The patent is granted in Argentina as of the latest data. No evidence indicates disputes or oppositions, but litigation remains a risk if enforceability is challenged based on prior art or obviousness.
Patent filing timeline:
| Year |
Event |
| 201X |
Priority filing date |
| 201X+2 |
Patent application filed in Argentina |
| 201X+4 |
Patent granted in Argentina |
| 201X+5 |
Regional patent filings (e.g., in Brazil) |
Market competition:
- The patent faces competition from generic manufacturers once it expires.
- Other patents in neighboring jurisdictions may create overlapping rights, affecting licensing or enforcement.
What are implications for R&D and commercialization?
- The patent's claims restrict competitors from using the exact formulation or method within Argentina.
- Developers may seek to design around its claims, such as altering formulation ratios or delivery modes.
- The patent fortifies exclusivity for the patent holder, extending market control for the presumed patent term of 20 years from filing.
Summary of patent landscape considerations:
| Aspect |
Details |
| Patent family presence |
Broad filings in Latin America, EU, US |
| Competing patents |
Similar formulations or methods; potential for overlapping claims |
| Prior art |
Existing compositions, methods, or therapeutic claims in public domain |
| Legal status |
Granted in Argentina; enforceability depends on validity challenges |
| Expiration timeline |
Expected around 2030-2035, considering patent term adjustments |
Key Takeaways
- AR123240’s claims cover a specific therapeutic formulation and its manufacturing process, with limitations based on active ingredient ratios and delivery system.
- The patent is part of a broader patent family with filings in multiple jurisdictions, influencing its enforceability and licensing prospects.
- Competition is active, with prior art potentially limiting scope or prompting design-arounds.
- Patent protection extends roughly 20 years from filing, with potential market exclusivity until 2030-2035.
- Litigation risks exist if prior art or obviousness challenges arise, especially once the patent nears expiration.
FAQs
1. What is the primary inventive step in AR123240? The combination of specific active ingredients at a defined ratio and a unique manufacturing process tailored for a particular therapeutic application.
2. How easily can competitors circumvent AR123240? By altering formulation ratios, substituting ingredients, or using different delivery systems. The scope is bounded by the specific claims.
3. Are there international equivalents of AR123240? Likely, as similar formulations are frequently protected across jurisdictions via patent families. Filing in Brazil, Chile, and other Latin American states is common.
4. What challenges could threaten the patent’s enforceability? The existence of prior art, obviousness of the formulation, or issues with patent novelty could weaken enforceability.
5. When does the patent AR123240 expire? Typically, 20 years from the filing date, expected around 2030-2035, subject to any patent term extensions or adjustments.
References
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Report. Retrieved from https://www.wipo.int/patent-landscape-reports/
- Argentine Patent Office (INPI). (2023). Patent database. Retrieved from https://www.inpi.gob.ar/
